PACB vs. SPY
Compare and contrast key facts about Pacific Biosciences of California, Inc. (PACB) and State Street SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Performance
PACB vs. SPY - Performance Comparison
Loading graphics...
PACB vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | -29.41% | 2.19% | -81.35% | 19.93% | -60.02% | -21.13% | 404.67% | -30.54% | 180.30% | -30.53% |
SPY State Street SPDR S&P 500 ETF | -4.37% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Returns By Period
In the year-to-date period, PACB achieves a -29.41% return, which is significantly lower than SPY's -4.37% return. Over the past 10 years, PACB has underperformed SPY with an annualized return of -17.78%, while SPY has yielded a comparatively higher 13.98% annualized return.
PACB
- 1D
- 4.76%
- 1M
- -21.43%
- YTD
- -29.41%
- 6M
- 3.13%
- 1Y
- 11.86%
- 3Y*
- -51.51%
- 5Y*
- -47.73%
- 10Y*
- -17.78%
SPY
- 1D
- 2.91%
- 1M
- -4.94%
- YTD
- -4.37%
- 6M
- -1.82%
- 1Y
- 17.59%
- 3Y*
- 18.19%
- 5Y*
- 11.69%
- 10Y*
- 13.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PACB vs. SPY — Risk / Return Rank
PACB
SPY
PACB vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PACB | SPY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.13 | 0.93 | -0.80 |
Sortino ratioReturn per unit of downside risk | 0.96 | 1.45 | -0.49 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.22 | -0.13 |
Calmar ratioReturn relative to maximum drawdown | 0.30 | 1.53 | -1.23 |
Martin ratioReturn relative to average drawdown | 0.63 | 7.30 | -6.67 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PACB | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.13 | 0.93 | -0.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.51 | 0.69 | -1.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.21 | 0.78 | -0.99 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.18 | 0.56 | -0.74 |
Correlation
The correlation between PACB and SPY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
PACB vs. SPY - Dividend Comparison
PACB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.14%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.14% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Drawdowns
PACB vs. SPY - Drawdown Comparison
The maximum PACB drawdown since its inception was -98.22%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PACB and SPY.
Loading graphics...
Drawdown Indicators
| PACB | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.22% | -55.19% | -43.03% |
Max Drawdown (1Y)Largest decline over 1 year | -52.81% | -12.05% | -40.76% |
Max Drawdown (5Y)Largest decline over 5 years | -97.47% | -24.50% | -72.97% |
Max Drawdown (10Y)Largest decline over 10 years | -98.22% | -33.72% | -64.50% |
Current DrawdownCurrent decline from peak | -97.42% | -6.24% | -91.18% |
Average DrawdownAverage peak-to-trough decline | -70.20% | -9.09% | -61.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.93% | 2.52% | +22.41% |
Volatility
PACB vs. SPY - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) has a higher volatility of 19.48% compared to State Street SPDR S&P 500 ETF (SPY) at 5.31%. This indicates that PACB's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PACB | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.48% | 5.31% | +14.17% |
Volatility (6M)Calculated over the trailing 6-month period | 66.55% | 9.47% | +57.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.97% | 19.05% | +72.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 93.91% | 17.06% | +76.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.47% | 17.92% | +66.55% |